Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Valsartan/amlodipine combination therapy versus amlodipine monotherapy in stage II hypertension
2006-000850-33Phase 3Terminated
- Sponsor
- Novartis
- Start
- Apr 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of valsartan, amlodipine and hydrochlorothiazide in hypertension (HTN) (2 arms), sponsored by Novartis. Started Apr 2006; status: terminated.
02
Drugs
valsartanamlodipinehydrochlorothiazide
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on 2006-000850-33.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-000850-33.